Literature DB >> 8149120

Psychiatric morbidity in the first-degree relatives of schizophrenic patients.

S L Varma1, I Sharma.   

Abstract

First-degree relatives (FDRs) of 162 schizophrenic and 106 control probands were investigated [corrected]. Psychiatric morbidity was present in 34.8% of FDRs of schizophrenic probands and in 9.2% of FDRs of controls. There was significantly more psychiatric illness in the siblings and parents than in the offspring of both schizophrenic and control subjects. The morbidity risks for schizoid-schizotypal personality disorders, cannabis-use disorder and paranoid personality disorder were significantly higher in the FDRs of schizophrenic patients than in those of controls, suggesting a biological relationship.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8149120     DOI: 10.1192/bjp.162.5.672

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

Review 1.  Defining the schizophrenia phenotype.

Authors:  G K Thaker
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

2.  Basal ganglia shape abnormalities in the unaffected siblings of schizophrenia patients.

Authors:  Daniel Mamah; Michael P Harms; Lei Wang; Deanna Barch; Paul Thompson; Jaeyun Kim; Michael I Miller; John G Csernansky
Journal:  Biol Psychiatry       Date:  2008-03-04       Impact factor: 13.382

Review 3.  Role of cannabis and endocannabinoids in the genesis of schizophrenia.

Authors:  Emilio Fernandez-Espejo; Maria-Paz Viveros; Luis Núñez; Bart A Ellenbroek; Fernando Rodriguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2009-07-24       Impact factor: 4.530

4.  Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia.

Authors:  Matthew J Smith; Deanna M Barch; Timothy J Wolf; Daniel Mamah; John G Csernansky
Journal:  Schizophr Res       Date:  2008-09-05       Impact factor: 4.939

5.  A controlled family study of cannabis users with and without psychosis.

Authors:  Ashley C Proal; Jerry Fleming; Juan A Galvez-Buccollini; Lynn E Delisi
Journal:  Schizophr Res       Date:  2013-12-02       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.